Investigating the mechanisms of small extracellular vesicles in cardiovascular disease using the living myocardial slice platform
File(s)
Published version
Author(s)
Koutentaki, Fani
Nicastro, laura
Kelwick, Richard
Freemont, Paul
Terracciano, Cesare
Type
Journal Article
Abstract
Cardiovascular disease remains the leading cause of death worldwide. Extracellular vesicles (EVs) play a regulatory role in homeostasis, associated with their contribution to cell-cell communication. Recently, it has been confirmed that they also regulate the progression of cardiovascular disease. Specifically, myocardial injury induces an increase in the secretion of small extracellular vesicles (sEVs), both in the cardiac microenvironment and peripheral circulation. Small extracellular vesicles (sEVs) are lipid bilayer particles within the size range of 35-200nm and are secreted by all cell types. Their high content of bioactive cargo – primarily miRNA – is altered in response to external stimuli, leading to behavioral changes of the recipient cells. In the context of cardiovascular disease, this change leads to acute and long term functional, structural, and biochemical effects on the myocardium. However, the mechanism behind the altered sEVs secretion and their changes in content in the context of cardiovascular disease is yet to be determined. That is partially due to the challenges associated with the isolation of cardiac-derived sEVs, which are essential for the investigation of the mechanisms behind cardiovascular disease progression. Living myocardial slices (LMS) provide an ideal platform for the isolation and investigation of sEVs function in the myocardium. Indeed, LMS not only maintain the cellular complexity and architecture of the native adult myocardium but can also be cultured over days/weeks without significant alterations in cardiac function, making them a reliable model for sEVs isolation and characterization at multiple timepoints. This review aims to summarize recent findings on the effect of sEVs on the onset and progression of cardiovascular disease and to discuss different methods for their isolation from LMSs and the investigation of their functional, structural, and biochemical effect on the myocardium.
Date Issued
2025-11-12
Date Acceptance
2025-10-16
Citation
Frontiers in Cardiovascular Medicine, 2025, 12
ISSN
2297-055X
Publisher
Frontiers Media S.A.
Journal / Book Title
Frontiers in Cardiovascular Medicine
Volume
12
Copyright Statement
© 2025 Koutentaki, Nicastro, Kelwick, Freemont and Terracciano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
License URL
Publication Status
Published
Article Number
1697099
Date Publish Online
2025-11-12